Abstract
Anorexia nervosa (AN) is a complex psychiatric disorder with both psychiatric and metabolic underpinnings. This study aims to explore the genetic architecture of AN and the interplay between its psychiatric and metabolic components. Through a meta-analysis of AN GWAS data from European and Finnish populations, we identified a novel genome-wide significant locus near the SOX5 gene. Genetic correlation and Mendelian randomization analyses revealed shared and potentially causal relationships between AN and multiple psychiatric and metabolic traits. Local genetic correlation analysis identified 185 significant genomic regions contributing to shared heritability between AN and correlated phenotypes, with 100 loci demonstrating pleiotropic effects across multiple traits. The MTAG analyses identified 86 significant loci (34 overlapping with local genetic correlation results), including 25 novel loci such as brain-relevant VAMP2 (17p13.1) and metabolic-neurological hubs LPL (8p21.3) and BDNF (11p14.1). Gene Co-expression Network Analysis (WGCNA) further identified key gene modules associated with both metabolic and neurological pathways, particularly highlighting synaptic signaling and lipid metabolism. Single-cell transcriptomic analysis further resolved this genetic risk to the cellular level, confirming its concentration in limbic and striatal GABAergic neurons and extending the implicated circuitry to include cortical regions involved in motor function. These findings collectively demonstrate the intricate genetic interplay between psychiatric and metabolic pathways in AN, underscoring the necessity of an integrated approach to understanding its pathogenesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout





Data availability
The GWAS summary statistics for AN were obtained from the Psychiatric Genomics Consortium (PGC) website (https://pgc.unc.edu/for-researchers/download-results/). The GWAS summary statistics for risk factors in Europeans were sourced from the Neale Lab UK Biobank GWAS web browser (http://www.nealelab.is/uk-biobank/). The GWAS summary statistics for AN and risk factors in the Finnish population were derived from the FinnGen consortium (https://r10.finngen.fi/).
Code availability
The code used in the present study is available in public repositories: plink (https://github.com/ chrchang/plink-ng), LDSC/S-LDSC (https://github.com/bulik/ldsc), TwoSampleMR (https://mrcieu.github.io/TwoSampleMR), LAVA (https://github.com/josefin-werme/LAVA), MTAG (https://github.com/JonJala/mtag), S‑PrediXcan/S‑MultiXcan (https://github.com/ hakyimlab/MetaXcan), WGCNA (https://cran.r-project.org/web/packages/WGCNA), g:Profiler (https://biit.cs.ut.ee/gprofiler/gost) and scDRS (https://github.com/martinjzhang/scDRS).
References
Kaye WH, Fudge JL, Paulus M. New insights into symptoms and neurocircuit function of anorexia nervosa. Nat Rev Neurosci. 2009;10:573–84.
Costandache GI, Munteanu O, Salaru A, Oroian B, Cozmin M. An overview of the treatment of eating disorders in adults and adolescents: pharmacology and psychotherapy. Postepy Psychiatrii Neurologii. 2023;32:40–8.
Duncan L, Yilmaz Z, Gaspar H, Walters R, Goldstein J, Anttila V, et al. Significant locus and metabolic genetic correlations revealed in genome-wide association study of anorexia nervosa. Am J Psychiatry. 2017;174:850–8.
Qian J, Wu Y, Liu F, Zhu Y, Jin H, Zhang H, et al. An update on the prevalence of eating disorders in the general population: a systematic review and meta-analysis. Eating and Weight Disorders: EWD. 2022;27:415–28.
Galmiche M, Déchelotte P, Lambert G, Tavolacci MP. Prevalence of eating disorders over the 2000-2018 period: a systematic literature review. Am J Clin Nutr. 2019;109:1402–13.
Yilmaz Z, Hardaway JA, Bulik CM. Genetics and epigenetics of eating disorders. Adv Genom Genet. 2015;5:131–50.
Negraes PD, Cugola FR, Herai RH, Trujillo CA, Cristino AS, Chailangkarn T, et al. Modeling anorexia nervosa: transcriptional insights from human iPSC-derived neurons. Transl Psychiatry. 2017;7:e1060.
Lutter M, Bahl E, Hannah C, Hofammann D, Acevedo S, Cui H, et al. Novel and ultra-rare damaging variants in neuropeptide signaling are associated with disordered eating behaviors. PLoS ONE. 2017;12:e0181556.
Boraska V, Franklin CS, Floyd JA, Thornton LM, Huckins LM, Southam L, et al. A genome-wide association study of anorexia nervosa. Mol Psychiatry. 2014;19:1085–94.
Nakabayashi K, Komaki G, Tajima A, Ando T, Ishikawa M, Nomoto J, et al. Identification of novel candidate loci for anorexia nervosa at 1q41 and 11q22 in Japanese by a genome-wide association analysis with microsatellite markers. J Hum Genet. 2009;54:531–7.
Wang K, Zhang H, Bloss CS, Duvvuri V, Kaye W, Schork NJ, et al. A genome-wide association study on common SNPs and rare CNVs in anorexia nervosa. Mol Psychiatry. 2011;16:949–59.
Watson HJ, Yilmaz Z, Thornton LM, Hübel C, Coleman JRI, Gaspar HA, et al. Genome-wide association study identifies eight risk loci and implicates metabo-psychiatric origins for anorexia nervosa. Nat Genet. 2019;51:1207–14.
Turley P, Walters RK, Maghzian O, Okbay A, Lee JJ, Fontana MA, et al. Multi-trait analysis of genome-wide association summary statistics using MTAG. Nat Genet. 2018;50:229–37.
Bang L, Bahrami S, Hindley G, Smeland OB, Rødevand L, Jaholkowski PP, et al. Genome-wide analysis of anorexia nervosa and major psychiatric disorders and related traits reveals genetic overlap and identifies novel risk loci for anorexia nervosa. Transl Psychiatry. 2023;13:291.
Lu ZA, Ploner A, Birgegård A, Bulik CM, Bergen SE. Shared genetic architecture between schizophrenia and anorexia nervosa: a cross-trait genome-wide analysis. Schizophr Bull. 2024;50:1255–65.
Keski-Rahkonen A, Mustelin L. Epidemiology of eating disorders in Europe: prevalence, incidence, comorbidity, course, consequences, and risk factors. Curr Opin Psychiatry. 2016;29:340–5.
Hudson JI, Hiripi E, Pope HG Jr., Kessler RC. The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry. 2007;61:348–58.
Micali N, Martini MG, Thomas JJ, Eddy KT, Kothari R, Russell E, et al. Lifetime and 12-month prevalence of eating disorders amongst women in mid-life: a population-based study of diagnoses and risk factors. BMC Med. 2017;15:12.
Kirk KM, Martin FC, Mao A, Parker R, Maguire S, Thornton LM, et al. The Anorexia Nervosa Genetics Initiative: Study description and sample characteristics of the Australian and New Zealand arm. Aust N Z J Psychiatry. 2017;51:583–94.
Thornton LM, Munn-Chernoff MA, Baker JH, Juréus A, Parker R, Henders AK, et al. The Anorexia Nervosa Genetics Initiative (ANGI): Overview and methods. Contemp Clin Trials. 2018;74:61–9.
Kurki MI, Karjalainen J, Palta P, Sipilä TP, Kristiansson K, Donner KM, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613:508–18.
Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562:203–9.
Dai Y, Hu R, Manuel AM, Liu A, Jia P, Zhao Z. CSEA-DB: an omnibus for human complex trait and cell type associations. Nucleic Acids Res. 2021;49:D862–d70.
Dai Y, Hu R, Liu A, Cho KS, Manuel AM, Li X, et al. WebCSEA: web-based cell-type-specific enrichment analysis of genes. Nucleic Acids Res. 2022;50:W782–w90.
Zhang MJ, Hou K, Dey KK, Sakaue S, Jagadeesh KA, Weinand K, et al. Polygenic enrichment distinguishes disease associations of individual cells in single-cell RNA-seq data. Nat Genet. 2022;54:1572–80.
Siletti K, Hodge R, Mossi Albiach A, Lee KW, Ding SL, Hu L, et al. Transcriptomic diversity of cell types across the adult human brain. Science. 2023;382:eadd7046.
Leone DP, Srinivasan K, Chen B, Alcamo E, McConnell SK. The determination of projection neuron identity in the developing cerebral cortex. Curr Opin Neurobiol. 2008;18:28–35.
Kwan KY, Lam MM, Krsnik Z, Kawasawa YI, Lefebvre V, Sestan N. SOX5 postmitotically regulates migration, postmigratory differentiation, and projections of subplate and deep-layer neocortical neurons. Proc Natl Acad Sci USA. 2008;105:16021–6.
Martinez-Morales PL, Quiroga AC, Barbas JA, Morales AV. SOX5 controls cell cycle progression in neural progenitors by interfering with the WNT-beta-catenin pathway. EMBO Rep. 2010;11:466–72.
Li A, Hooli B, Mullin K, Tate RE, Bubnys A, Kirchner R, et al. Silencing of the Drosophila ortholog of SOX5 leads to abnormal neuronal development and behavioral impairment. Hum Mol Genet. 2017;26:1472–82.
Quiroga AC, Stolt CC, Diez del Corral R, Dimitrov S, Pérez-Alcalá S, Sock E, et al. Sox5 controls dorsal progenitor and interneuron specification in the spinal cord. Dev Neurobiol. 2015;75:522–38.
Baroti T, Zimmermann Y, Schillinger A, Liu L, Lommes P, Wegner M, et al. Transcription factors Sox5 and Sox6 exert direct and indirect influences on oligodendroglial migration in spinal cord and forebrain. Glia. 2016;64:122–38.
Pardiñas AF, Holmans P, Pocklington AJ, Escott-Price V, Ripke S, Carrera N, et al. Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection. Nat Genet. 2018;50:381–9.
Howard DM, Adams MJ, Clarke TK, Hafferty JD, Gibson J, Shirali M, et al. Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nat Neurosci. 2019;22:343–52.
Coleman JRI, Gaspar HA, Bryois J, Breen G. The Genetics of the Mood Disorder Spectrum: Genome-wide Association Analyses of More Than 185,000 Cases and 439,000 Controls. Biol Psychiatry. 2020;88:169–84.
Cross-Disorder Group of the Psychiatric Genomics Consortium. Genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders. Cell 2019;179:1469–82.e1411.
Sinha R, Ahmed S, Jahn R, Klingauf J. Two synaptobrevin molecules are sufficient for vesicle fusion in central nervous system synapses. Proc Natl Acad Sci USA. 2011;108:14318–23.
Koo SJ, Kochlamazashvili G, Rost B, Puchkov D, Gimber N, Lehmann M, et al. Vesicular synaptobrevin/VAMP2 levels guarded by AP180 control efficient neurotransmission. Neuron. 2015;88:330–44.
Chiang CW, Chang CW, Jackson MB. The transmembrane domain of synaptobrevin influences neurotransmitter flux through synaptic fusion pores. J Neurosci. 2018;38:7179–91.
Salpietro V, Malintan NT, Llano-Rivas I, Spaeth CG, Efthymiou S, Striano P, et al. Mutations in the neuronal vesicular SNARE VAMP2 affect synaptic membrane fusion and impair human neurodevelopment. Am J Hum Genet. 2019;104:721–30.
Chanaday NL, Kavalali ET. Synaptobrevin-2 dependent regulation of single synaptic vesicle endocytosis. Mol Biol Cell. 2021;32:1818–23.
Hussain AA, Hübel C, Hindborg M, Lindkvist E, Kastrup AM, Yilmaz Z, et al. Increased lipid and lipoprotein concentrations in anorexia nervosa: A systematic review and meta-analysis. Int J Eat Disord. 2019;52:611–29.
Park H, Poo MM. Neurotrophin regulation of neural circuit development and function. Nat Rev Neurosci. 2013;14:7–23.
Foltran RB, Diaz SL. BDNF isoforms: a round trip ticket between neurogenesis and serotonin? J Neurochem. 2016;138:204–21.
Sasi M, Vignoli B, Canossa M, Blum R. Neurobiology of local and intercellular BDNF signaling. Pflugers Archiv: Eur J Physiol. 2017;469:593–610.
Kowiański P, Lietzau G, Czuba E, Waśkow M, Steliga A, Moryś J. BDNF: a key factor with multipotent impact on brain signaling and synaptic plasticity. Cell Mol Neurobiol. 2018;38:579–93.
Acknowledgements
The study was supported by grants from the Special Funds of Taishan Scholar Project, China (tsqn202211224), the National Natural Science Foundation of China (32270661), Excellent Youth Science Fund Project (Overseas) of Shandong China (2023HWYQ-082), the China Postdoctoral Science Foundation (2024M761870), Shandong Postdoctoral Science Foundation (SDCX-ZG-202400042) and Shandong Province Higher Education Institution Youth Innovation and Technology Support Program (2023KJ179).
Author information
Authors and Affiliations
Contributions
XC and HH conceptualized and designed the study; YCS and YJ collected the data; YCS and YJ analyzed the data; HT and JG performed the validation analyses; YCS and YJ drafted the manuscript, XC and HH revised the manuscript. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors report no biomedical financial interests or potential conflicts of interest.
Ethics approval and consent to participate
This study used only publicly available summary-level data from previously published studies. No individual-level data were accessed and no new human or animal subjects were involved. All analyses were conducted in accordance with relevant guidelines and regulations. Ethical approval and informed consent were therefore not required.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Song, Y., Jiang, Y., Tian, H. et al. Integrative GWAS identifies novel loci and genetic links between psychiatric and metabolic factors in anorexia nervosa. Mol Psychiatry (2026). https://doi.org/10.1038/s41380-026-03591-7
Received:
Revised:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41380-026-03591-7